Roman Viktorovich Ishchenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Roman Viktorovich Ishchenko has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Andrey Gennadievich Popandopulo
Laboratory of Cell and Tissue Cultivation, Federal State Budgetary Institution “V.K. Gusak Institute of Emergency and Reconstructive Surgery” of the Ministry of Health of the Russian Federation, Donetsk 283045, Russia
4 shared publications - Dmitry Alekseevich Filimonov
Federal State Budgetary Institution “V.K. Gusak Institute of Emergency and Reconstructive Surgery” of the Ministry of Health of the Russian Federation, Donetsk 283045, Russia
4 shared publications - Maksim Vital'Evich Solopov
Laboratory of Cell and Tissue Cultivation, Federal State Budgetary Institution “V.K. Gusak Institute of Emergency and Reconstructive Surgery” of the Ministry of Health of the Russian Federation, Donetsk 283045, Russia
4 shared publications - Oksana Yu. Stukalova
ALLORO Medical Center
4 shared publications - Viktor V. Turchin
Laboratory of Cell and Tissue Cultivation, Federal State Budgetary Institution “V.K. Gusak Institute of Emergency and Reconstructive Surgery” of the Ministry of Health of the Russian Federation, Donetsk 283045, Russia
4 shared publications - Aleksey Aleksandrovich Polikarpov
ФГБУ «Российский научный центр радиологии и хирургических технологий им. акад. А.М. Гранова» МЗ РФ
3 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by ECO-Vector LLC (Publications) in Journal of Clinical Practice
The first experience with dynamic magnetic retraction in laparoscopic colon resections: a prospective study of 12 hospital cases
Objective. To evaluate the clinical safety and efficacy of a new dynamic magnetic retraction system with electronic control of magnetic field strength and six-axis positioning to ensure adequate exposure of the surgical field in patients undergoing elective laparoscopic colon resections. Methods. A prospective descriptive study included patients aged 46 to 78 years with histologically verified cancer of the cecal, ascending, descending, or sigmoid colon, who were scheduled for elective laparoscopic surgery at a single surgical hospital. The intervention studied was the intraoperative use of a dynamic-controlled magnetic system. The primary endpoint was the incidence of intraoperative complications associated with the use of the magnetic device. Additional outcomes: duration of surgery, volume of blood loss, number of removed lymph nodes, frequency of R0 resection, frequency of postoperative complications, time of restoration of peristalsis, and duration of hospitalization. Results. The study included 12 patients (7 men, 5 women; median age 64 years). In all cases, the system provided adequate visualization of the surgical field without conversion to an open intervention or the installation of additional trochars. There were no intraoperative complications associated with the magnetic device (0%; 95% confidence interval 0–26.5). The median duration of surgery was 170 minutes, and the median blood loss was 50 ml. The median number of lymph nodes removed was 12 (range 8–18). R0 resection was achieved in all 12 patients. Peristaltic activity was restored on the second day, and the median hospital stay was 10 days. One case of postoperative wound seroma was recorded (8.3%; 1/12), and no deaths were reported. Conclusions. Dynamic magnetic retraction with smooth adjustment of force and traction vector is safe and provides adequate oncological results in laparoscopic colon resections. Due to the small sample size and the absence of a comparison group, it is currently not possible to assess the superiority of this method over standard approaches.
- 14 October 2026
- Published by ECO-Vector LLC (Publications) in Journal of Clinical Practice
Open AccessThe first experience with dynamic magnetic retraction in laparoscopic colon resections: a prospective study of 12 hospital cases
Objective. To evaluate the clinical safety and efficacy of a new dynamic magnetic retraction system with electronic control of magnetic field strength and six-axis positioning to ensure adequate exposure of the surgical field in patients undergoing elective laparoscopic colon resections. Methods. A prospective descriptive study included patients aged 46 to 78 years with histologically verified cancer of the cecal, ascending, descending, or sigmoid colon, who were scheduled for elective laparoscopic surgery at a single surgical hospital. The intervention studied was the intraoperative use of a dynamic-controlled magnetic system. The primary endpoint was the incidence of intraoperative complications associated with the use of the magnetic device. Additional outcomes: duration of surgery, volume of blood loss, number of removed lymph nodes, frequency of R0 resection, frequency of postoperative complications, time of restoration of peristalsis, and duration of hospitalization. Results. The study included 12 patients (7 men, 5 women; median age 64 years). In all cases, the system provided adequate visualization of the surgical field without conversion to an open intervention or the installation of additional trochars. There were no intraoperative complications associated with the magnetic device (0%; 95% confidence interval 0–26.5). The median duration of surgery was 170 minutes, and the median blood loss was 50 ml. The median number of lymph nodes removed was 12 (range 8–18). R0 resection was achieved in all 12 patients. Peristaltic activity was restored on the second day, and the median hospital stay was 10 days. One case of postoperative wound seroma was recorded (8.3%; 1/12), and no deaths were reported. Conclusions. Dynamic magnetic retraction with smooth adjustment of force and traction vector is safe and provides adequate oncological results in laparoscopic colon resections. Due to the small sample size and the absence of a comparison group, it is currently not possible to assess the superiority of this method over standard approaches.
- Open Access
- 30 August 2026
- Published by Institute of Cytology and Genetics, SB RAS in Siberian Scientific Medical Journal
- Vol. 46 (4) , 138-148
Robotic XY-scanning platform for three-dimensional analysis of ex vivo models of superficial wounds
Accurate measurement of wound geometric parameters is essential for assessing injury severity and monitoring healing progress. Traditional manual methods have significant limitations: high error rates, subjectivity, and risk of infection. Modern digital techniques lack these drawbacks but are often expensive and complex. This study presents an alternative solution: an automated scanning platform assembled from affordable components. Aim of the study was to develop and validate a robotic XY-scanning platform for automated 3D analysis of ex vivo models of superficial skin wounds and to evaluate its accuracy compared to standard manual measurement methods. Material and methods. The hardware of the platform was developed using an Arduino Uno microcontroller, 28BYJ-48 stepper motors, and a Sharp 2Y0A21 infrared distance sensor. The software controls the scanning process and calculates wound parameters: volume (using Simpson’s method), area (using the Gaussian formula), and maximum depth. For validation, six model wounds with varying geometries were created on porcine skin samples. Their parameters were independently measured by the automated system and manual methods: volume by filling with saline solution, depth with a caliper, and area by planimetry in ImageJ software. Results. Statistical analysis demonstrated high agreement between automated and manual measurements. The highest accuracy was achieved in volume assessment: the mean difference between methods (0.37 cm 3 , p = 0.156), Spearman’s (ρ = 1.00) and Lin’s concordance correlation coefficient (> 0.98) indicated nearly perfect concordance. Depth measurements also showed high reliability, despite a minor systematic underestimation by the automated system averaging 0.99 mm (p = 0.094). A strong monotonic relationship was confirmed (ρ = 0.94). For wound area, a statistically significant systematic bias was identified: the platform consistently overestimated values by an average of 1.98 cm 2 (p = 0.031), likely due to hardware limitations and insufficient system resolution. Conclusions. The developed platform proved effective for automated, non-contact measurement of wound volume and depth, combining component affordability and automation. The main limitation is a systematic error in area measurement. Future work involves hardware modernization (installing a high-precision laser sensor) and further validation on an expanded sample of various wound types for implementation in clinical and research practice.
- 30 August 2026
- Published by Institute of Cytology and Genetics, SB RAS in Siberian Scientific Medical Journal
- Vol. 46 (4) , 138-148
Open AccessRobotic XY-scanning platform for three-dimensional analysis of ex vivo models of superficial wounds
Accurate measurement of wound geometric parameters is essential for assessing injury severity and monitoring healing progress. Traditional manual methods have significant limitations: high error rates, subjectivity, and risk of infection. Modern digital techniques lack these drawbacks but are often expensive and complex. This study presents an alternative solution: an automated scanning platform assembled from affordable components. Aim of the study was to develop and validate a robotic XY-scanning platform for automated 3D analysis of ex vivo models of superficial skin wounds and to evaluate its accuracy compared to standard manual measurement methods. Material and methods. The hardware of the platform was developed using an Arduino Uno microcontroller, 28BYJ-48 stepper motors, and a Sharp 2Y0A21 infrared distance sensor. The software controls the scanning process and calculates wound parameters: volume (using Simpson’s method), area (using the Gaussian formula), and maximum depth. For validation, six model wounds with varying geometries were created on porcine skin samples. Their parameters were independently measured by the automated system and manual methods: volume by filling with saline solution, depth with a caliper, and area by planimetry in ImageJ software. Results. Statistical analysis demonstrated high agreement between automated and manual measurements. The highest accuracy was achieved in volume assessment: the mean difference between methods (0.37 cm 3 , p = 0.156), Spearman’s (ρ = 1.00) and Lin’s concordance correlation coefficient (> 0.98) indicated nearly perfect concordance. Depth measurements also showed high reliability, despite a minor systematic underestimation by the automated system averaging 0.99 mm (p = 0.094). A strong monotonic relationship was confirmed (ρ = 0.94). For wound area, a statistically significant systematic bias was identified: the platform consistently overestimated values by an average of 1.98 cm 2 (p = 0.031), likely due to hardware limitations and insufficient system resolution. Conclusions. The developed platform proved effective for automated, non-contact measurement of wound volume and depth, combining component affordability and automation. The main limitation is a systematic error in area measurement. Future work involves hardware modernization (installing a high-precision laser sensor) and further validation on an expanded sample of various wound types for implementation in clinical and research practice.
- Open Access
- 11 April 2026
- Published by ECO-Vector LLC (Publications) in Journal of Clinical Practice
- Vol. 17 (1) , 86-95
Therapeutic effects of probiotics in topical treatment of infected wounds
Wound infections, exacerbated by antibiotic resistance and biofilm formation, necessitate alternative therapeutic options. One promising approach is topical bacteriotherapy with live probiotics. The work aimed to summarize existing research on the multifaceted effects of live probiotics in infected wound healing. The review examines how probiotics directly influence pathogenic wound microflora by competing for adhesion sites and nutrients, secreting antagonistic compounds, altering the wound environment, and promoting co-aggregation. Probiotics’ antibiofilm activity is highlighted, including inhibition of quorum sensing systems and disruption of the extracellular biofilm matrix. Moreover, the review discusses the findings of in vitro and in vivo studies on the effects of live probiotics on macroorganisms. Probiotics have been shown to activate signaling pathways that regulate macrophage shift from a pro-inflammatory (M1) phenotype to a pro-repair (M2) phenotype, cytokine synthesis, keratinocyte and fibroblast migration and proliferation, angiogenesis, and collagen matrix formation. Thus, the multifaceted effects of probiotics cannot be replicated by metabolites or inactivated cells alone, highlighting the need for effective delivery systems for live probiotic cultures in infected wound management.
- 11 April 2026
- Published by ECO-Vector LLC (Publications) in Journal of Clinical Practice
- Vol. 17 (1) , 86-95
Open AccessTherapeutic effects of probiotics in topical treatment of infected wounds
Wound infections, exacerbated by antibiotic resistance and biofilm formation, necessitate alternative therapeutic options. One promising approach is topical bacteriotherapy with live probiotics. The work aimed to summarize existing research on the multifaceted effects of live probiotics in infected wound healing. The review examines how probiotics directly influence pathogenic wound microflora by competing for adhesion sites and nutrients, secreting antagonistic compounds, altering the wound environment, and promoting co-aggregation. Probiotics’ antibiofilm activity is highlighted, including inhibition of quorum sensing systems and disruption of the extracellular biofilm matrix. Moreover, the review discusses the findings of in vitro and in vivo studies on the effects of live probiotics on macroorganisms. Probiotics have been shown to activate signaling pathways that regulate macrophage shift from a pro-inflammatory (M1) phenotype to a pro-repair (M2) phenotype, cytokine synthesis, keratinocyte and fibroblast migration and proliferation, angiogenesis, and collagen matrix formation. Thus, the multifaceted effects of probiotics cannot be replicated by metabolites or inactivated cells alone, highlighting the need for effective delivery systems for live probiotic cultures in infected wound management.
- Open Access
- 13 March 2026
- Published by ECO-Vector LLC (Publications) in Genes & Cells
- Vol. 21 (1) , 62-76
Magnetic particles and targeting systems for magnetic cell delivery
BACKGROUND: The number of studies investigating physical methods of cell targeting is steadily growing. Within the field of magnetic cell targeting, two main approaches have recently emerged: the use of microscale structures as magnetic carriers, e.g, porous spheroids, helices, and microrobots, that transport cells, and the use of nano- or microscale magnetic particles that directly label cells. AIM: The study aimed to review experimental studies on the use of magnetic particles for targeted delivery of mammalian cells in order to identify the main parameters of magnetic labeling and targeting systems. METHODS: Scientific data was searched in the PubMed, Cochrane Library, and eLIBRARY.RU databases for the period from January 2019 to September 2024 using the keywords magnetic cell targeting, magnetic cell delivery, magnetic cell localization, and magnetic cell guidance. Original experimental in vitro and in vivo studies were included if they involved labeling mammalian or human cells with magnetic nano- or microparticles for targeted delivery using magnetic fields. Data on study design, cell lines used, characteristics of magnetic particles, magnetic labeling conditions and efficiency, characteristics of magnetic trapping systems, efficiency of magnetic delivery, and clinical effects in in vivo disease models were extracted from the selected articles. RESULTS: A total of 62 articles were included in the analysis, of which 63% (39 studies) involved animal disease models, mainly affecting the nervous system, heart, eyes, urinary system, musculoskeletal system, and cancer. The most common labeled cells were multipotent mesenchymal stromal cells (27 studies), immune system cells (16 studies), and endothelial cells and their progenitors (7 studies). In most studies, superparamagnetic iron oxide nanoparticles were used for cell labeling (82% of studies) with more than 30 types of coatings, whereas neodymium magnets of various configurations at 0.005–1.450 T magnetic induction served as targeting systems. In 84% of studies, the optimal labeling concentration of magnetic particles ranged from 10–100 µg Fe/mL, with a labeling time of 4–24 h. A high degree of labeled cell magnetic controllability was demonstrated in vitro. In 19 animal studies, magnetic targeting resulted in a 1.16- to 20-fold increase in local cell concentration within the target area. In 85% of in vivo studies, magnetic targeting produced a more pronounced therapeutic effect compared with controls without targeting systems. Overall, the analysis confirms the high clinical potential of magnetic targeting in cell therapy. CONCLUSION: Magnetic targeting of cells using magnetic particles is a rapidly developing and promising technology in the field of regenerative medicine and cell therapy.
- 13 March 2026
- Published by ECO-Vector LLC (Publications) in Genes & Cells
- Vol. 21 (1) , 62-76
Open AccessMagnetic particles and targeting systems for magnetic cell delivery
BACKGROUND: The number of studies investigating physical methods of cell targeting is steadily growing. Within the field of magnetic cell targeting, two main approaches have recently emerged: the use of microscale structures as magnetic carriers, e.g, porous spheroids, helices, and microrobots, that transport cells, and the use of nano- or microscale magnetic particles that directly label cells. AIM: The study aimed to review experimental studies on the use of magnetic particles for targeted delivery of mammalian cells in order to identify the main parameters of magnetic labeling and targeting systems. METHODS: Scientific data was searched in the PubMed, Cochrane Library, and eLIBRARY.RU databases for the period from January 2019 to September 2024 using the keywords magnetic cell targeting, magnetic cell delivery, magnetic cell localization, and magnetic cell guidance. Original experimental in vitro and in vivo studies were included if they involved labeling mammalian or human cells with magnetic nano- or microparticles for targeted delivery using magnetic fields. Data on study design, cell lines used, characteristics of magnetic particles, magnetic labeling conditions and efficiency, characteristics of magnetic trapping systems, efficiency of magnetic delivery, and clinical effects in in vivo disease models were extracted from the selected articles. RESULTS: A total of 62 articles were included in the analysis, of which 63% (39 studies) involved animal disease models, mainly affecting the nervous system, heart, eyes, urinary system, musculoskeletal system, and cancer. The most common labeled cells were multipotent mesenchymal stromal cells (27 studies), immune system cells (16 studies), and endothelial cells and their progenitors (7 studies). In most studies, superparamagnetic iron oxide nanoparticles were used for cell labeling (82% of studies) with more than 30 types of coatings, whereas neodymium magnets of various configurations at 0.005–1.450 T magnetic induction served as targeting systems. In 84% of studies, the optimal labeling concentration of magnetic particles ranged from 10–100 µg Fe/mL, with a labeling time of 4–24 h. A high degree of labeled cell magnetic controllability was demonstrated in vitro. In 19 animal studies, magnetic targeting resulted in a 1.16- to 20-fold increase in local cell concentration within the target area. In 85% of in vivo studies, magnetic targeting produced a more pronounced therapeutic effect compared with controls without targeting systems. Overall, the analysis confirms the high clinical potential of magnetic targeting in cell therapy. CONCLUSION: Magnetic targeting of cells using magnetic particles is a rapidly developing and promising technology in the field of regenerative medicine and cell therapy.
- Open Access
- 22 July 2025
- Published by Endocrinology Research Centre in Problems of Endocrinology
- Vol. 71 (3) , 4-13
Prospects for the application of convolutional neural networks in the cytological diagnosis of thyroid nodules
Перспективы применения свёрточных нейронных сетей в цитологической диагностике узловых образований щитовидной железы
- 22 July 2025
- Published by Endocrinology Research Centre in Problems of Endocrinology
- Vol. 71 (3) , 4-13
Open AccessProspects for the application of convolutional neural networks in the cytological diagnosis of thyroid nodules
Перспективы применения свёрточных нейронных сетей в цитологической диагностике узловых образований щитовидной железы
- Open Access
- 17 May 2025
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 24 (2) , 144-149
Comparative characteristics of embolization and ligation of the right branch of the portal vein (literature review)
The purpose of the study was to compare the methods of mechanical reduction of blood flow in the right branch of the portal vein: portal vein embolization (PVE) and portal vein ligation (PVL) as a neoadjuvant treatment before extended hepatectomy to induce hypertrophy of the future liver remnant (FLR) for the prevention of post-resection hepatic failure (PRHF). Material and Methods. A total of 28 publications from PubMed and ScienceDirect databases, the International Hepato-Pancreato-Biliary Association, monographs and guidelines for physicians, covering the period from 2001 to 2004, were analyzed. The search for articles in the PubMed database was conducted using the key words: “portal vein embolization” and “portal vein ligation” with the parameters “Free full text”, “Review”, “5 years”. 22 articles were selected as relevant. Conclusion. In general, no clear and unanimous opinion was found among the authors regarding the rate of FLR hypertrophy between the PVE and PVL methods. However, most authors recommended PVL. As for the time interval from PVE/PVL to the second stage of surgery, the opinions were equally bipolar. Many authors recommended additional segment IV embolization to enhance the regenerative potential, which is associated with technical difficulties and requires advanced skills. The problem of post-occlusion tumor progression was widely reported, the highest percentage of cases was described after PVE. This fact is explained by hemodynamic restructuring, stimulation of cytokine and growth factor production. The cases of insufficient FLR hypertrophy due to the development of intrahepatic collaterals, especially after PVL, were described. Associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) was proposed as an alternative to prevent this complication. Complications after PVE/PVL were poorly described, with isolated reports of contralateral embolization, intra-abdominal choleraemia or hemorrhage, and distant periportal fibrosis. To date, PVE remains the gold standard as the first stage of two-stage extensive liver resections, as a prevention of post-resection liver failure.
- 17 May 2025
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 24 (2) , 144-149
Open AccessComparative characteristics of embolization and ligation of the right branch of the portal vein (literature review)
The purpose of the study was to compare the methods of mechanical reduction of blood flow in the right branch of the portal vein: portal vein embolization (PVE) and portal vein ligation (PVL) as a neoadjuvant treatment before extended hepatectomy to induce hypertrophy of the future liver remnant (FLR) for the prevention of post-resection hepatic failure (PRHF). Material and Methods. A total of 28 publications from PubMed and ScienceDirect databases, the International Hepato-Pancreato-Biliary Association, monographs and guidelines for physicians, covering the period from 2001 to 2004, were analyzed. The search for articles in the PubMed database was conducted using the key words: “portal vein embolization” and “portal vein ligation” with the parameters “Free full text”, “Review”, “5 years”. 22 articles were selected as relevant. Conclusion. In general, no clear and unanimous opinion was found among the authors regarding the rate of FLR hypertrophy between the PVE and PVL methods. However, most authors recommended PVL. As for the time interval from PVE/PVL to the second stage of surgery, the opinions were equally bipolar. Many authors recommended additional segment IV embolization to enhance the regenerative potential, which is associated with technical difficulties and requires advanced skills. The problem of post-occlusion tumor progression was widely reported, the highest percentage of cases was described after PVE. This fact is explained by hemodynamic restructuring, stimulation of cytokine and growth factor production. The cases of insufficient FLR hypertrophy due to the development of intrahepatic collaterals, especially after PVL, were described. Associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) was proposed as an alternative to prevent this complication. Complications after PVE/PVL were poorly described, with isolated reports of contralateral embolization, intra-abdominal choleraemia or hemorrhage, and distant periportal fibrosis. To date, PVE remains the gold standard as the first stage of two-stage extensive liver resections, as a prevention of post-resection liver failure.
- Open Access
- 18 November 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (4) , 29-37
Main aspects of personalized approach to the treatment of patients with chemotherapy resistant metastatic colorectal cancer
Purpose of the study. To improve the results of treatment of patients with unresectable metastases of colorectal cancer in the liver that are not controlled by systemic chemotherapy.Materials and methods. The study includes clinical data on the treatment of 76 patients with metachronous metastases of colorectal cancer in the liver that are not controlled by systemic chemotherapy. Patients underwent removal of the primary tumor according to urgent indications at the first stage of complex treatment, followed by systemic chemotherapy in an adjuvant mode. After 24.5 ± 0.2 months, patients were diagnosed with metastatic liver damage, and therefore systemic chemotherapy was initiated. After changing two lines of drug therapy with a registered progression of the oncological process, liver metastases were recognized as uncontrolled by systemic chemotherapy. After that patients were included in the given study and divided into two groups. The study group included 40 patients who underwent regional chemotherapy. The control group included 36 patients who continued systemic chemotherapy with subsequent line changes. The effectiveness was evaluated according to the RECIST 1.1 and mRECIST scales, as well as the overall one-year, two- and three-year survival rates.Results. The median overall survival of patients in the control and study groups was 30.0 ± 0.8 and 41.5 ± 0.5 months, respectively, p < 0.05. The total one-year, two- and three-year survival of patients in the control and study groups was 94.4 %, 69.4 %, 33.3 % and 100 %, 82.5 %, 57.5 %, respectively, p < 0.05. The median life expectancy of deceased patients in the control and study groups was 22.5 ± 0.4 and 27.0 ± 0.4 months.Conclusions. As a result of a comparative analysis of the detection of adverse events and complications of the treatment, patients of the study group underwent treatment much easier than patients of the control group – in patients in the group of systemic chemotherapy, moderate and severe complications were detected in 44.4 % of cases, in the study group – in 2.5 % of cases. According to the results of a clinical study, regional chemotherapy is an effective method of treating patients with colon cancer metastases in the liver that are not controlled by systemic chemotherapy and is associated with a statistically significant increase in overall survival (p < 0.05). For a more detailed study of the benefits of regional chemotherapy in this category of patients, further prospective clinical studies are necessary.
- 18 November 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (4) , 29-37
Open AccessMain aspects of personalized approach to the treatment of patients with chemotherapy resistant metastatic colorectal cancer
Purpose of the study. To improve the results of treatment of patients with unresectable metastases of colorectal cancer in the liver that are not controlled by systemic chemotherapy.Materials and methods. The study includes clinical data on the treatment of 76 patients with metachronous metastases of colorectal cancer in the liver that are not controlled by systemic chemotherapy. Patients underwent removal of the primary tumor according to urgent indications at the first stage of complex treatment, followed by systemic chemotherapy in an adjuvant mode. After 24.5 ± 0.2 months, patients were diagnosed with metastatic liver damage, and therefore systemic chemotherapy was initiated. After changing two lines of drug therapy with a registered progression of the oncological process, liver metastases were recognized as uncontrolled by systemic chemotherapy. After that patients were included in the given study and divided into two groups. The study group included 40 patients who underwent regional chemotherapy. The control group included 36 patients who continued systemic chemotherapy with subsequent line changes. The effectiveness was evaluated according to the RECIST 1.1 and mRECIST scales, as well as the overall one-year, two- and three-year survival rates.Results. The median overall survival of patients in the control and study groups was 30.0 ± 0.8 and 41.5 ± 0.5 months, respectively, p < 0.05. The total one-year, two- and three-year survival of patients in the control and study groups was 94.4 %, 69.4 %, 33.3 % and 100 %, 82.5 %, 57.5 %, respectively, p < 0.05. The median life expectancy of deceased patients in the control and study groups was 22.5 ± 0.4 and 27.0 ± 0.4 months.Conclusions. As a result of a comparative analysis of the detection of adverse events and complications of the treatment, patients of the study group underwent treatment much easier than patients of the control group – in patients in the group of systemic chemotherapy, moderate and severe complications were detected in 44.4 % of cases, in the study group – in 2.5 % of cases. According to the results of a clinical study, regional chemotherapy is an effective method of treating patients with colon cancer metastases in the liver that are not controlled by systemic chemotherapy and is associated with a statistically significant increase in overall survival (p < 0.05). For a more detailed study of the benefits of regional chemotherapy in this category of patients, further prospective clinical studies are necessary.
- Open Access
- 15 November 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (4) , 20-28
Improvement of long-term treatment results in oligometastatic colorectal cancer patients by using a combined approach
Purpose of the study. To improve the treatment results of patients suffering from CRC with oligometastatic lesion by determining the most effective combination of treatment methods.Patients and methods. The results of treatment of 71 patients with oligometastases of colorectal cancer were analyzed. All patients were divided into 2 groups depending on the treatment methods. The first group included 35 patients who underwent simultaneous removal of the primary tumor and metastatic foci at the first stage of complex treatment. The second group includes clinical data on 36 patients who underwent primary lesion removal at the first stage of complex treatment followed by drug antitumor therapy.Results. In the primary tumor removal group, the response was received in 3 (8.3 %) cases, stabilization was achieved in 14 (38.9 %) cases, and progression of the tumor process was detected in 19 (52.8 %) cases. The median disease-free survival was 9.2 ± 3.2 months. One-year, two- and three-year survival rates in the group of simultaneous removal of the primary tumor and oligometastases and in the group of primary tumor removal were 97.1 %, 88.6 %, 77.1 % and 100 %, 80.5 %, 72.2 %, respectively. The overall survival rate in the group of simultaneous removal of the primary tumor and oligometastases was 63 ± 3.9 months, in the group of primary tumor removal – 58 ± 3.8 months.Conclusion. In the presented clinical study, a comparative assessment of the effectiveness of the treatment of patients with colorectal cancer with oligometastases was carried out, depending on the option of an integrated approach. The results obtained turned out to be multidirectional – the response to treatment and progression were obtained in 54.3 % and 45.7 % of cases in the group of simultaneous removal of the primary tumor and oligometastases versus 47.2 % and 52.8 % of cases in the group of removal of the primary tumor without oligometastases, respectively. The median recurrence-free survival was shorter in the group of primary tumor removal without metastases. Complete removal of the primary tumor and oligometastases can significantly increase the overall survival rates of patients.
- 15 November 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (4) , 20-28
Open AccessImprovement of long-term treatment results in oligometastatic colorectal cancer patients by using a combined approach
Purpose of the study. To improve the treatment results of patients suffering from CRC with oligometastatic lesion by determining the most effective combination of treatment methods.Patients and methods. The results of treatment of 71 patients with oligometastases of colorectal cancer were analyzed. All patients were divided into 2 groups depending on the treatment methods. The first group included 35 patients who underwent simultaneous removal of the primary tumor and metastatic foci at the first stage of complex treatment. The second group includes clinical data on 36 patients who underwent primary lesion removal at the first stage of complex treatment followed by drug antitumor therapy.Results. In the primary tumor removal group, the response was received in 3 (8.3 %) cases, stabilization was achieved in 14 (38.9 %) cases, and progression of the tumor process was detected in 19 (52.8 %) cases. The median disease-free survival was 9.2 ± 3.2 months. One-year, two- and three-year survival rates in the group of simultaneous removal of the primary tumor and oligometastases and in the group of primary tumor removal were 97.1 %, 88.6 %, 77.1 % and 100 %, 80.5 %, 72.2 %, respectively. The overall survival rate in the group of simultaneous removal of the primary tumor and oligometastases was 63 ± 3.9 months, in the group of primary tumor removal – 58 ± 3.8 months.Conclusion. In the presented clinical study, a comparative assessment of the effectiveness of the treatment of patients with colorectal cancer with oligometastases was carried out, depending on the option of an integrated approach. The results obtained turned out to be multidirectional – the response to treatment and progression were obtained in 54.3 % and 45.7 % of cases in the group of simultaneous removal of the primary tumor and oligometastases versus 47.2 % and 52.8 % of cases in the group of removal of the primary tumor without oligometastases, respectively. The median recurrence-free survival was shorter in the group of primary tumor removal without metastases. Complete removal of the primary tumor and oligometastases can significantly increase the overall survival rates of patients.
- Open Access
- 26 August 2023
- Published by Russian Gastroenterolgocial Society in Russian Journal of Gastroenterology, Hepatology, Coloproctology
- Vol. 33 (3) , 76-84
Surgical Strategy in Patients with Complete Transposition of Internal Organs in Cancer of the Biliopancreatoduodenal Zone
Аim: to present two clinical cases of successful surgical treatment of patients with a combination of complete transposition of internal organs and cancer of the biliopancreatoduodenal zone.Key points. A 65-year-old man underwent gastropancreatoduodenal resection for cancer of the large duodenal papilla. In addition to the situs vicserum inversus, this patient revealed a special variant of vascular anatomy, namely: separate separation of the left and right hepatic arteries from the ventral trunk. A 70-year-old man, in addition to complete transposition of internal organs, had a combination of cancer of the terminal part of the common bile duct and heterotaxy syndrome in the form of polysplenia, aplasia of the hepatic segment of the inferior vena cava, agenesis of the dorsal pancreatic rudiment (“short” pancreas), intrapancreatic course of the right hepatic artery extending from the superior mesenteric arteries, rotational abnormalities of intestinal development. This patient underwent a total pancreatectomy. In both cases, the main difficulties in mobilizing the pancreatoduodenal complex arose due to anatomical disorientation and the absence of standard (familiar) topographic and anatomical landmarks for the surgeon.Conclusion. In all patients with tumors of the biliopancreatoduodenal zone, a detailed assessment of the vascular anatomy of this area is required before surgery, with the study of the course of the main visceral vessels and their large branches using multispiral computed tomography in vascular mode. If heterotaxy syndrome is suspected, additional examination is necessary to identify hidden developmental anomalies, which allows surgeons to be prepared for an unusual situation. Gastropancreatoduodenal resection or total pancreatectomy in situs viscerum inversus is a technically complex intervention and should be performed in large multidisciplinary medical institutions, and the operating team should have extensive experience in operations on the organs of the biliopancreatoduodenal zone.
- 26 August 2023
- Published by Russian Gastroenterolgocial Society in Russian Journal of Gastroenterology, Hepatology, Coloproctology
- Vol. 33 (3) , 76-84
Open AccessSurgical Strategy in Patients with Complete Transposition of Internal Organs in Cancer of the Biliopancreatoduodenal Zone
Аim: to present two clinical cases of successful surgical treatment of patients with a combination of complete transposition of internal organs and cancer of the biliopancreatoduodenal zone.Key points. A 65-year-old man underwent gastropancreatoduodenal resection for cancer of the large duodenal papilla. In addition to the situs vicserum inversus, this patient revealed a special variant of vascular anatomy, namely: separate separation of the left and right hepatic arteries from the ventral trunk. A 70-year-old man, in addition to complete transposition of internal organs, had a combination of cancer of the terminal part of the common bile duct and heterotaxy syndrome in the form of polysplenia, aplasia of the hepatic segment of the inferior vena cava, agenesis of the dorsal pancreatic rudiment (“short” pancreas), intrapancreatic course of the right hepatic artery extending from the superior mesenteric arteries, rotational abnormalities of intestinal development. This patient underwent a total pancreatectomy. In both cases, the main difficulties in mobilizing the pancreatoduodenal complex arose due to anatomical disorientation and the absence of standard (familiar) topographic and anatomical landmarks for the surgeon.Conclusion. In all patients with tumors of the biliopancreatoduodenal zone, a detailed assessment of the vascular anatomy of this area is required before surgery, with the study of the course of the main visceral vessels and their large branches using multispiral computed tomography in vascular mode. If heterotaxy syndrome is suspected, additional examination is necessary to identify hidden developmental anomalies, which allows surgeons to be prepared for an unusual situation. Gastropancreatoduodenal resection or total pancreatectomy in situs viscerum inversus is a technically complex intervention and should be performed in large multidisciplinary medical institutions, and the operating team should have extensive experience in operations on the organs of the biliopancreatoduodenal zone.
- Open Access
- 3 July 2022
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 13 (2) , 59-65
X-ray-endovascular interventions in the treatment of patients with liver metastases of colorectal cancer after the termination of systemic chemotherapy
Background: At present, the problem of treating common forms of colorectal cancer does not lose its relevance due to the increase in its incidence. Systemic chemotherapy is the main line of treatment for patients with unresectable liver metastases. However, a significant problem of modern oncology is the further treatment tactics for patients with chemoresistant metastases. Aims: to improve the treatment results for patients with chemoresistant liver metastases of colorectal cancer. Method: 36 patients with unresectable liver metastases of colorectal cancer were treated at the Granov Russian Research Center of Radiology and Surgical Technologies and the RZD-Medicine Central Clinical Hospital. For all the patients, systemic chemotherapy was considered unreasonable due to the development of chemoresistance or a high degree of toxicity. The patients underwent regional chemotherapy chemoinfusion and/or chemoembolization of the hepatic artery. Results: The treatment evaluation was performed using the RECIST 1.1 scale. After 6 months, a partial response was reached in 1 patient (2.8%), stabilization was observed in 29 (80.5%) patients, and 6 patients (16.7%) had the disease progression. In 2 (5.6%) cases, a lethal outcome was observed against the background of the systemic progression of the oncological disease. One year later, stabilization of the malignant process was detected in 21 (58.3%) cases, progression was detected in 15 (41.7%) cases. A one-year survival of patients was 83.3%, the overall survival 22 months. Conclusion: The use of interventional radiology methods has shown its effectiveness in patients with unresectable chemoresistant liver metastases of colorectal cancer.
- 3 July 2022
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 13 (2) , 59-65
Open AccessX-ray-endovascular interventions in the treatment of patients with liver metastases of colorectal cancer after the termination of systemic chemotherapy
Background: At present, the problem of treating common forms of colorectal cancer does not lose its relevance due to the increase in its incidence. Systemic chemotherapy is the main line of treatment for patients with unresectable liver metastases. However, a significant problem of modern oncology is the further treatment tactics for patients with chemoresistant metastases. Aims: to improve the treatment results for patients with chemoresistant liver metastases of colorectal cancer. Method: 36 patients with unresectable liver metastases of colorectal cancer were treated at the Granov Russian Research Center of Radiology and Surgical Technologies and the RZD-Medicine Central Clinical Hospital. For all the patients, systemic chemotherapy was considered unreasonable due to the development of chemoresistance or a high degree of toxicity. The patients underwent regional chemotherapy chemoinfusion and/or chemoembolization of the hepatic artery. Results: The treatment evaluation was performed using the RECIST 1.1 scale. After 6 months, a partial response was reached in 1 patient (2.8%), stabilization was observed in 29 (80.5%) patients, and 6 patients (16.7%) had the disease progression. In 2 (5.6%) cases, a lethal outcome was observed against the background of the systemic progression of the oncological disease. One year later, stabilization of the malignant process was detected in 21 (58.3%) cases, progression was detected in 15 (41.7%) cases. A one-year survival of patients was 83.3%, the overall survival 22 months. Conclusion: The use of interventional radiology methods has shown its effectiveness in patients with unresectable chemoresistant liver metastases of colorectal cancer.